Best Gallbladder Cancer Doctors in Hyderabad — CION's Dedicated HPB & Gallbladder Cancer Panel

The best doctor for gallbladder cancer is an HPB-trained surgical oncologist (hepatopancreatobiliary) — not a general surgeon. Gallbladder cancer surgery often requires partial liver resection (typically segments IVb and V) and portal lymph node dissection, which requires specific HPB onco-training. For chemotherapy and advanced disease, a medical oncologist current with gemcitabine + cisplatin and emerging targeted therapies. At CION, every gallbladder cancer case is reviewed by a multidisciplinary tumour board, with HPB surgery led by Dr. Vajja Sandeep Kumar (DrNB Surgical Oncology, FALS Oncology).

This is the most common way gallbladder cancer is diagnosed — incidentally, after laparoscopic cholecystectomy for what was thought to be gallstones alone. The next step is critical: review of the pathology report by a surgical oncologist to determine stage (T1a, T1b, T2, T3, T4), and decision on whether re-resection is needed. T1a tumours generally do not need further surgery. T1b and above usually require re-operation for radical cholecystectomy with hepatic segment resection and portal lymph node dissection — ideally within 4–8 weeks of the original surgery. Many general surgical centres do not refer patients for this re-resection, which is a meaningful avoidable error in gallbladder cancer care. CION specifically reviews every incidental gallbladder cancer case for re-resection eligibility.

Yes, in most cases beyond T1a. Radical cholecystectomy involves removing the gallbladder along with adjacent liver tissue (typically segments IVb and V, immediately around the gallbladder bed) and the portal lymph nodes. For larger tumours, more extensive hepatic resection may be required. This surgery requires HPB (hepatopancreatobiliary) surgical training — not all surgical oncologists offer it. At CION, our HPB surgical pathway is led by Dr. Vajja Sandeep Kumar (FALS Oncology), the same team that handles complex liver cancer surgery.

Once gallbladder cancer is suspected or confirmed, treatment must be led by oncology — not a general surgeon. Gallbladder cancer surgery requires HPB-trained surgical oncology for the radical resection (gallbladder + liver + lymph nodes). A general surgeon performing the original cholecystectomy is appropriate for gallstones; once cancer is identified, the patient must move to an HPB surgical oncologist for any further surgery. A general gastroenterologist or hepatologist is not the right specialist for gallbladder cancer surgical treatment.

Radical cholecystectomy is the onco-specific surgery for gallbladder cancer. Unlike simple cholecystectomy (which just removes the gallbladder), radical cholecystectomy removes the gallbladder, adjacent liver tissue (typically segments IVb and V), and the portal lymph nodes — the regional drainage area where cancer typically spreads first. For larger tumours, extended hepatectomy or bile duct resection may be added. The procedure requires HPB surgical training and is the standard of care for T1b and above gallbladder cancers.

India — particularly the Indo-Gangetic belt — has one of the highest gallbladder cancer incidences globally, with a striking female predominance (approximately 7 women for every 1 man). The exact reasons are not fully understood but include the very high prevalence of chronic gallstones in Indian women (chronic gallbladder inflammation is the dominant risk factor), genetic factors, dietary patterns, and possibly environmental factors. Women with long-standing gallstones, large gallstones (over 3 cm), gallbladder polyps, or porcelain gallbladder are at elevated risk and warrant specialist evaluation.

Adjuvant chemotherapy (capecitabine for 6 months) is recommended after surgery for most gallbladder cancers beyond T1a. For advanced or metastatic disease, gemcitabine plus cisplatin is the standard first-line chemotherapy. For patients with specific molecular alterations (FGFR2 fusions, IDH1 mutations, BRAF V600E, HER2 amplification), emerging targeted therapies are increasingly available. CION's medical oncology team offers all current NCCN preferred regimens and molecular testing where indicated.

Cure rates depend heavily on stage at diagnosis. T1a gallbladder cancer (limited to the inner gallbladder wall) has near-100% cure rate after simple cholecystectomy. T1b and T2 cancers, when treated with appropriate radical cholecystectomy, have meaningful long-term survival. T3 and T4 cancers carry worse prognosis but modern combined treatment (surgery where feasible, chemotherapy, and targeted therapy where applicable) has meaningfully improved outcomes. The single biggest factor in outcomes — beyond stage — is whether the patient receives appropriate radical resection rather than simple cholecystectomy alone.

A second opinion is essential for any gallbladder cancer case — particularly when the cancer was found incidentally after gallstone surgery. The questions of whether re-resection is needed, when it should happen, and what extent of liver resection is appropriate vary meaningfully across centres. At CION the second opinion is free, written, and yours to keep — our HPB tumour board reviews your pathology, imaging, and existing surgical notes, and provides a documented opinion you can take anywhere.

Costs vary by stage and treatment. Radical cholecystectomy with limited hepatic resection ranges approximately ₹3,00,000 to ₹6,00,000; extended hepatectomy ranges higher; adjuvant capecitabine chemotherapy adds ₹1,00,000 to ₹2,00,000 over six months; gemcitabine + cisplatin for advanced disease adds substantially. For a detailed cost breakdown by treatment type, see our gallbladder cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins. Aarogyasri, EMI, and cashless insurance are accepted.